Moderna Inc (MRNA)
108.86
+0.98
(+0.91%)
USD |
NASDAQ |
Apr 24, 16:00
109.00
+0.14
(+0.13%)
After-Hours: 18:48
Moderna Gross Profit (Quarterly): 1.884B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.884B |
| September 30, 2023 | -454.00M |
| June 30, 2023 | -415.00M |
| March 31, 2023 | 1.046B |
| December 31, 2022 | 3.231B |
| September 30, 2022 | 2.12B |
| June 30, 2022 | 3.185B |
| March 31, 2022 | 4.923B |
| Date | Value |
|---|---|
| December 31, 2021 | 5.997B |
| September 30, 2021 | 4.107B |
| June 30, 2021 | 3.465B |
| March 31, 2021 | 1.55B |
| December 31, 2020 | 221.00M |
| September 30, 2020 | 12.00M |
| June 30, 2020 | 29.00M |
| March 31, 2020 | 4.00M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-454.00M
Minimum
Sep 2023
5.997B
Maximum
Dec 2021
1.932B
Average
1.717B
Median
Gross Profit (Quarterly) Benchmarks
| Merck & Co Inc | 10.72B |
| Pfizer Inc | 6.686B |
| Eli Lilly and Co | 7.565B |
| Johnson & Johnson | 14.87B |
| Novavax Inc | 98.42M |